These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 7550031

  • 1. Amino- and amido-tetrabenazine derivatives: synthesis and evaluation as potential ligands for the vesicular monoamine transporter.
    Canney DJ, Kung MP, Kung HF.
    Nucl Med Biol; 1995 May; 22(4):527-35. PubMed ID: 7550031
    [Abstract] [Full Text] [Related]

  • 2. In vitro and in vivo studies of benzisoquinoline ligands for the brain synaptic vesicle monoamine transporter.
    Lee LC, Vander Borght T, Sherman PS, Frey KA, Kilbourn MR.
    J Med Chem; 1996 Jan 05; 39(1):191-6. PubMed ID: 8568807
    [Abstract] [Full Text] [Related]

  • 3. Binding of alpha-dihydrotetrabenazine to the vesicular monoamine transporter is stereospecific.
    Kilbourn M, Lee L, Vander Borght T, Jewett D, Frey K.
    Eur J Pharmacol; 1995 May 24; 278(3):249-52. PubMed ID: 7589162
    [Abstract] [Full Text] [Related]

  • 4. Synthesis of a [11C]methoxy derivative of alpha-dihydrotetrabenazine: a radioligand for studying the vesicular monoamine transporter.
    DaSilva JN, Kilbourn MR, Mangner TJ.
    Appl Radiat Isot; 1993 Dec 24; 44(12):1487-9. PubMed ID: 7903060
    [Abstract] [Full Text] [Related]

  • 5. Synthesis and biological evaluation of 3-alkyl-dihydrotetrabenazine derivatives as vesicular monoamine transporter-2 (VMAT2) ligands.
    Zheng P, Lieberman BP, Choi SR, Plöessl K, Kung HF.
    Bioorg Med Chem Lett; 2011 Jun 01; 21(11):3435-8. PubMed ID: 21531556
    [Abstract] [Full Text] [Related]

  • 6. Peptide mapping of the [125I]Iodoazidoketanserin and [125I]2-N-[(3'-iodo-4'-azidophenyl)propionyl]tetrabenazine binding sites for the synaptic vesicle monoamine transporter.
    Sievert MK, Ruoho AE.
    J Biol Chem; 1997 Oct 10; 272(41):26049-55. PubMed ID: 9325342
    [Abstract] [Full Text] [Related]

  • 7. Rapid and differential losses of in vivo dopamine transporter (DAT) and vesicular monoamine transporter (VMAT2) radioligand binding in MPTP-treated mice.
    Kilbourn MR, Kuszpit K, Sherman P.
    Synapse; 2000 Mar 15; 35(4):250-5. PubMed ID: 10657034
    [Abstract] [Full Text] [Related]

  • 8. Synthesis and evaluation of 2-amino-dihydrotetrabenzine derivatives as probes for imaging vesicular monoamine transporter-2.
    Zhu L, Liu J, Kung HF.
    Bioorg Med Chem Lett; 2009 Sep 01; 19(17):5026-8. PubMed ID: 19632829
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Reserpine affects differentially the density of the vesicular monoamine transporter and dihydrotetrabenazine binding sites.
    Naudon L, Raisman-Vozari R, Edwards RH, Leroux-Nicollet I, Peter D, Liu Y, Costentin J.
    Eur J Neurosci; 1996 Apr 01; 8(4):842-6. PubMed ID: 9081637
    [Abstract] [Full Text] [Related]

  • 12. Effects of nerve growth factor on dihydrotetrabenazine binding to PC12 cells.
    Adamson CR, Emley TE, Herbig LJ, Near JA.
    Neurochem Int; 1997 Apr 01; 30(4-5):411-5. PubMed ID: 9106255
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Decreased densities of dopamine and serotonin transporters and of vesicular monoamine transporter 2 in severely kainic acid lesioned subregions of the striatum.
    Naudon L, Leroux-Nicollet I, Boulay D, Costentin J.
    J Neural Transm (Vienna); 2001 Apr 01; 108(4):431-44. PubMed ID: 11475010
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. In vivo measures of dopaminergic radioligands in the rat brain: equilibrium infusion studies.
    Kilbourn MR, Sherman PS, Kuszpit K.
    Synapse; 2002 Mar 01; 43(3):188-94. PubMed ID: 11793424
    [Abstract] [Full Text] [Related]

  • 17. In vivo imaging of the brain vesicular monoamine transporter.
    Vander Borght TM, Kilbourn MR, Koeppe RA, DaSilva JN, Carey JE, Kuhl DE, Frey KA.
    J Nucl Med; 1995 Dec 01; 36(12):2252-60. PubMed ID: 8523116
    [Abstract] [Full Text] [Related]

  • 18. Transient expression of the vesicular monoamine transporter during development in the rat thalamus and cortex.
    Leroux-Nicollet I, Costentin J.
    Neurosci Lett; 1998 Jun 05; 248(3):167-70. PubMed ID: 9654335
    [Abstract] [Full Text] [Related]

  • 19. Chronic clozapine, but not haloperidol, treatment affects rat brain vesicular monoamine transporter 2.
    Rehavi M, Roz N, Weizman A.
    Eur Neuropsychopharmacol; 2002 Jun 05; 12(3):261-8. PubMed ID: 12007678
    [Abstract] [Full Text] [Related]

  • 20. In vivo binding of (+)-alpha-[3H]dihydrotetrabenazine to the vesicular monoamine transporter of rat brain: bolus vs. equilibrium studies.
    Kilbourn M, Sherman P.
    Eur J Pharmacol; 1997 Jul 23; 331(2-3):161-8. PubMed ID: 9274975
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.